MetLife Investment Management’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-15,180
Closed -$903K 2368
2019
Q3
$903K Hold
15,180
0.01% 1121
2019
Q2
$711K Hold
15,180
0.01% 1285
2019
Q1
$590K Hold
15,180
0.01% 1357
2018
Q4
$573K Hold
15,180
0.01% 1283
2018
Q3
$1.04M Hold
15,180
0.01% 1103
2018
Q2
$794K Hold
15,180
0.01% 1133
2018
Q1
$794K Hold
15,180
0.01% 1114
2017
Q4
$729K Buy
+15,180
New +$752K 0.01% 1184

Other funds holding CBM

MetLife Investment Management's CBM Position: Q4 2019 in Review

MetLife Investment Management sold out of Cambrex Corporation (CBM) in Q4 2019, closing a stake of 15,180 shares — an estimated $903K sold.

MetLife Investment Management first reported a position in CBM in Q4 2017 and held it in 8 quarters. The position peaked at $1.04M in Q3 2018. 1 fund tracked by Wall St. Rank holds CBM as of Q4 2019.

  • MetLife Investment Management reported no remaining Cambrex Corporation position as of Q4 2019 after selling out during the quarter.
  • MetLife Investment Management sold 15,180 Cambrex Corporation shares in Q4 2019, an estimated $903K.
  • MetLife Investment Management first reported a position in Cambrex Corporation in Q4 2017 and held it in 8 quarters.
  • MetLife Investment Management's Cambrex Corporation position peaked at $1.04M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Cambrex Corporation as of Q4 2019.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.